CSIMarket
Company Name or Ticker Symbol
Search for other Categories
 


Albireo Pharma, Inc.  (ALBO)
Other Ticker:  
 
    Sector  Healthcare    Industry Major Pharmaceutical Preparations
 

Albireo Pharma's Gross Margin by quarter

Trends, Rankings, Statistics

Select the Comparisons : Select the Ratio:                        

ALBO Gross Margin (Jun 30 2017)
II. Quarter
(Mar 31 2017)
I. Quarter
(Dec 31 2016)
IV. Quarter


Y / Y Revenue Change - - - - -
Y / Y Gross Profit Change - - - - -
Gross Margin - - - - -
Gross Margin Total Ranking # 520 # 575 # 507 # #
Seq. Revenue Change 0 % - - - -
Seq. Gross Profit Change - - - - -


Commenting Second Quarter 2017 Gross Margin
Albireo Pharma, Inc. experienced contraction in Gross Profit by 0 % to $0 millions and Revenue by 0 %, while Gross Margin fell to 100 % a new company low.

Observing second quarter 2017 results within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Gross Margin. While overall Gross Margin ranking remained unchanged compare to previous quarter at no. .
Learn about Gross Margin
ALBO's Gross Margin second quarter 2017 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 63
Healthcare Sector # 138
Overall # 520

Gross Margin Statistics
High Average Low
100 % 100 % 100 %
(Jun 30 2017)  

You need to upgrade your Flash Player


Financial Statements
Albireo Pharma's (Jun 30 2017) Gross Profit $ 0 ALBO's Income Statement
Albireo Pharma's Gross Profit $ 0 Quarterly ALBO's Growth
ALBO's Profits by Division See ALBO's Profits by Segment

Other Gross Margin Profitability Ratios
ALBO's Cumulative Gross Margin
Major Pharmaceutical Preparations Industry Gross Margin Trends and Statistics
Healthcare Sector Gross Margin Statistics
Gross Margin Profitability Trends for overall market
ALBO's Gross Margin Profitability versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Gross Margin
Lowest Ranking Gross Margin
Gross Margin Profit Margin for ALBO's Competitors
Gross Margin Profit Margin for Albireo Pharma's Suppliers
Gross Margin Profit Margin for ALBO's Customers

You may also want to know
ALBO's Annual Growth Rates ALBO's Profitability Ratios ALBO's Asset Turnover Ratio ALBO's Dividend Growth
ALBO's Roe ALBO's Valuation Ratios ALBO's Financial Strength Ratios ALBO's Gross Profit Growth
ALBO's Roa ALBO's Inventory Turnover Ratio ALBO's Growth Rates ALBO's Dividend Comparisons


Companies with similar Gross Margin in the quarter ending Jun 30 2017, within Major Pharmaceutical Preparations Industry Gross MarginJun 30 2017 MRQ Gross ProfitJun 30 2017 MRQ Revenue
Endocyte Inc  100.00 %$ 0.013 $ 0.013 
Dynavax Technologies Corp  100.00 %$ 0.105 $ 0.105 
Ophthotech Corp.  100.00 %$ 1.661 $ 1.661 
Onconova Therapeutics, Inc.  100.00 %$ 0.324 $ 0.324 
Enanta Pharmaceuticals Inc  100.00 %$ 7.511 $ 7.511 
Evoke Pharma Inc  100.00 %$ 1.262 $ 1.262 
Epizyme, Inc.  100.00 %$ 10.000 $ 10.000 
Dicerna Pharmaceuticals Inc  100.00 %$ 0.252 $ 0.252 
Dermira, Inc.  100.00 %$ 1.066 $ 1.066 
Corbus Pharmaceuticals Holdings, Inc.  100.00 %$ 0.350 $ 0.350 
Abeona Therapeutics Inc.  100.00 %$ 0.217 $ 0.217 
Conatus Pharmaceuticals Inc.  100.00 %$ 10.008 $ 10.008 
Paratek Pharmaceuticals, Inc.  100.00 %$ 7.514 $ 7.514 
Prothena Corp Plc  100.00 %$ 26.812 $ 26.812 
Progenics Pharmaceuticals Inc  100.00 %$ 2.765 $ 2.765 
Cytokinetics Inc  100.00 %$ 3.053 $ 3.053 
Eyegate Pharmaceuticals Inc  100.00 %$ 0.148 $ 0.148 
Fibrogen Inc  100.00 %$ 28.997 $ 28.997 
Karyopharm Therapeutics Inc.  100.00 %$ 0.003 $ 0.003 
Seres Therapeutics, Inc.  100.00 %$ 3.014 $ 3.014 
Immunogen Inc  100.00 %$ 39.020 $ 39.020 
Kalvista Pharmaceuticals, Inc.  100.00 %$ 0.096 $ 0.096 
Jazz Pharmaceuticals Plc  100.00 %$ 394.386 $ 394.386 
Intra-cellular Therapies, Inc.  100.00 %$ 0.115 $ 0.115 
Ionis Pharmaceuticals Inc  100.00 %$ 104.152 $ 104.152 
Ibio, Inc.  100.00 %$ 0.147 $ 0.147 
Macrogenics Inc  100.00 %$ 1.666 $ 1.666 
Five Prime Therapeutics Inc  100.00 %$ 7.822 $ 7.822 
Northwest Biotherapeutics Inc  100.00 %$ 0.088 $ 0.088 
Oncomed Pharmaceuticals Inc  100.00 %$ 6.195 $ 6.195 
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

SMED's Profile

Stock Price

SMED's Financials

SMED's Expectations

Business Description

Fundamentals

Charts & Quotes

SMED's News

Suppliers

SMED's Competitors

Customers & Markets

Economic Indicators

SMED's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Expectations

Management Effectivness

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us



CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2017 CSIMarket, Inc. All rights reserved. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)
Intraday Data provided by Barchart and subject to terms of use. To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Stock Price, historical and current end-of-day data provided by eoddata. Intraday data delayed per exchange requirements. S&P/Dow Jones Indices (SM) from Barchart and Eoddata. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com